References [i] Tomas M, et al
Featured Expert Steven J
264,268 Released at the guts end, GLP-1 acts on its receptors in the gastrointestinal tract, leading to reduced gastric muscle contractions and extended food retention in the stomach
Safety Considerations and Contraindications Sermorelin Safety Profile Sermorelin's adverse event profile from clinical trials includes injection-site reactions (erythema, swelling in approximately 17% of pediatric patients in the key trial), transient facial flushing, and headache
Customers should review the medication vial, outer packaging, and pharmacy information sheet for: Inactive ingredients and preservatives Compounding solution or buffer Declared allergens Storage requirements Beyond-use date Lot and pharmacy information Anyone with medication allergies or sensitivity to an injectable ingredient should discuss this with the prescribing provider and dispensing pharmacist before using the medication
Rapid weight loss associated with retatrutide may indirectly alter skin barrier function, causing dryness or heightened sensitivity